Search research articles
Contact Us
Filters
Showing results (371-380 of 403) with videos related to
Page
of 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age
Milagritos D Tapia, Helen Findlow, Olubukola T Idoko, et al.
The Lancet. Child & Adolescent Health
|
March 19, 2021
SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study
Shamez N Ladhani, Frances Baawuah, Joanne Beckmann, et al.
Vaccine
|
September 18, 2025
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers
Abraham Hodgson, Fadima Cheick Haidara, Samba O Sow, et al.
Vaccine
|
January 22, 2019
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
Alessandro Muzzi, Alessandro Brozzi, Laura Serino, et al.
The Journal of Infection
|
October 22, 2023
Meningococcal disease in the Middle East: A report from the Global Meningococcal Initiative
Seif S Al-Abri, Musallam Yunus Abuhasan, Soha Shawqi A Albayat, et al.
The New England Journal of Medicine
|
June 17, 2011
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
Samba O Sow, Brown J Okoko, Aldiouma Diallo, et al.
Eclinicalmedicine
|
October 5, 2021
Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
Georgina Ireland, Anna Jeffery-Smith, Maria Zambon, et al.
Expert Review of Vaccines
|
December 12, 2018
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations
Reinaldo Acevedo, Xilian Bai, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years
Aldiouma Diallo, Samba O Sow, Olubukola T Idoko, et al.
Mbio
|
March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
Lisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 403) with videos related to
Sort By:
Page
of 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age
Milagritos D Tapia, Helen Findlow, Olubukola T Idoko, et al.
The Lancet. Child & Adolescent Health
|
March 19, 2021
SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study
Shamez N Ladhani, Frances Baawuah, Joanne Beckmann, et al.
Vaccine
|
September 18, 2025
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers
Abraham Hodgson, Fadima Cheick Haidara, Samba O Sow, et al.
Vaccine
|
January 22, 2019
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
Alessandro Muzzi, Alessandro Brozzi, Laura Serino, et al.
The Journal of Infection
|
October 22, 2023
Meningococcal disease in the Middle East: A report from the Global Meningococcal Initiative
Seif S Al-Abri, Musallam Yunus Abuhasan, Soha Shawqi A Albayat, et al.
The New England Journal of Medicine
|
June 17, 2011
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
Samba O Sow, Brown J Okoko, Aldiouma Diallo, et al.
Eclinicalmedicine
|
October 5, 2021
Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
Georgina Ireland, Anna Jeffery-Smith, Maria Zambon, et al.
Expert Review of Vaccines
|
December 12, 2018
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations
Reinaldo Acevedo, Xilian Bai, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years
Aldiouma Diallo, Samba O Sow, Olubukola T Idoko, et al.
Mbio
|
March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
Lisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
Page
of 41